Product
SLMAP and EPO genetic polymorphism
1 clinical trial
1 indication
Indication
Diabetic RetinopathyClinical trial
Evaluation of the Relationship Between SLMAP and EPO Genetic Polymorphism and the Risk of Diabetic Retinopathy in Egyptian Diabetic Patients: A Case-Control StudyStatus: Completed, Estimated PCD: 2023-04-30